Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$853,834
-$13,305 QoQ
Shares Held
87,215
-2.2% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 187 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. PRTA ranks #160 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in PRTA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $853,834 | 87,215 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $867,139 | 89,212 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,006,961 | 105,441 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,030,030 | 105,536 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $919,865 | 151,543 | Shares | Defined | 2025-08-14 | |
| 2023-12-31 | $500,038 | 13,760 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $533,789 | 11,063 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $813,624 | 11,916 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $582,221 | 12,012 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,456,844 | 24,180 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,081,608 | 34,333 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $684,422 | 25,209 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,033,320 | 28,256 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $712,348 | 14,420 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $649,831 | 9,123 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $446,934 | 17,792 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $493,238 | 41,069 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $498,280 | 49,878 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $490,259 | 46,870 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $502,738 | 46,985 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||